Bristol Myers Squibb’s Zeposia (ozanimod) Receives CHMP’s Positive Opinion for Adult Patients with Moderately to Severely Active Ulcerative Colitis Published: 15 Oct, 2021 | Tags: Bristol Myers Squibb, Zeposia, ozanimod, […]readmore
Tags : Adamas
Shots: Supernus signs a definitive agreement to acquire Adamas for $8.10/ share in cash (~$400M) & 2 non-tradable CVR of ~$1.00 00/share in cash (~$50M) based on sales of GOCOVRI, […]readmore